Circulating erythropoietin in patients with myelodysplastic syndromes

British Journal of Haematology

Volumn 73, Issue 1, 1989, Pages 36-39

  Jacobs, A ^a   Janowska Wieczorek A ^b   Caro, J ^c   Bowen, D T ^a   Lewis, T ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF ALBERTA   (Canada)

^c THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN;

ADULT; ANEMIA; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; METHODOLOGY; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; BONE MARROW; ERYTHROBLASTS; ERYTHROPOIETIN; FEMALE; HEMOGLOBINS; HUMAN; MALE; MIDDLE AGE; MYELODYSPLASTIC SYNDROMES;

EID: 0024448197     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.1989.tb00215.x     Document Type: Article

References (31)

1. Proposals for the classification of the myelodysplastic syndromes
2. Serum erythropoietin levels by radioimmunoassay in polycythaemia
3. Biologic and immunologic erythropoietin in extracts from hypoxic whole rat kidneys and in their glomerular and tubular fractions
4. Transcriptional activations of the erythropoietin gene in response to hypoxia or cobalt
5. Quantitative evaluation of erythropoietic activity in dysmyelopoietic syndromes
6. Immunoreactive erythropoietin in serum. I. Evidence for the validity of the assay method and the physiological relevance of estimates
7. Reduced erthropoietin, levels as a cause of anaemia in patients with lung cancer
8. Serum erythropoietin (ESF) titres in anemia
9. Mechanisms and prognostic value of cell kinetics in the myelodysplastic syndromes
10. Humoral regulation of red cell production
11. Plasma erythropoietin in health and disease
12. Radioimmunoassay of erythropoietin circulating levels in normal and polycythemic human beings
13. Production, utilisation and excretion of erythropoietin. I. Chronic anemias. II. Aplastic crisis. III. Erythropoietic effects of normal plasma
14. Pathogenesis and clinical variations in the myelodysplastic syndromes
15. Role of the kidney in erythropoiesis
16. Studies on the production of erythropoietin by isolated perfused organs
17. Granulopoietic and erythropoietic activity in patients with anemias of iron deficiency and chronic disease
18. The myelodysplastic syndrome: analysis of laboratory characteristics in relation to the FAB classification
19. Erythropoietin responses to anaemia in children with sickle cell disease and Fanconi's hypoproliferative anaemia
20. Bone marrow culture studies in refractory cytopenia and ‘smouldering leukaemia’
21. Synthesis of erythropoietin by human erythroleukaemic cells
22. A radio‐immunoassay for erythropoietin. Serum levels in normal human subjects and patients with hemopoietic disorders
23. Erythroid and granulocyte‐macrophage colony formation in myelodysplastic syndromes
24. Regulation of erythropoietin secretion in vitro by a beta‐adrenergic mechanism
25. Sickle cell anemia patients have low erythropoietin levels for their degree of anaemia
26. The mechanisms of action of erythropoietin
27. Humoral regulation of erythropoiesis V. Relationship of plasma erythropoietin level to bone marrow activity
28. Regulation of erythropoietin and burst‐promoting activity production in patients with aplastic anaemia and iron deficiency anaemia
29. Levels of erythropoietin in patients with the anemia of chronic diseases and liver failure
30. Serum level of erythropoietin in anemias associated with chronic infection. malignancy and primary hematopoietic disease